These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 1530450)

  • 1. [Pseudomonas aeruginosa and cystic fibrosis. Risks of contamination].
    Mouterde O; Massot J; Vassal S
    Arch Fr Pediatr; 1992 May; 49(5):476-7. PubMed ID: 1530450
    [No Abstract]   [Full Text] [Related]  

  • 2. Cross-infection with Pseudomonas aeruginosa among patients with cystic fibrosis.
    Agarwal G; Kapil A; Kabra SK; Das BK
    Natl Med J India; 2006; 19(4):236-7. PubMed ID: 17103494
    [No Abstract]   [Full Text] [Related]  

  • 3. Environmental contamination with an epidemic strain of Pseudomonas aeruginosa in a Liverpool cystic fibrosis centre, and study of its survival on dry surfaces.
    Panagea S; Winstanley C; Walshaw MJ; Ledson MJ; Hart CA
    J Hosp Infect; 2005 Feb; 59(2):102-7. PubMed ID: 15620443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transmission of Pseudomonas aeruginosa epidemic strain from a patient with cystic fibrosis to a pet cat.
    Mohan K; Fothergill JL; Storrar J; Ledson MJ; Winstanley C; Walshaw MJ
    Thorax; 2008 Sep; 63(9):839-40. PubMed ID: 18728207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microbiologic contamination study of nebulizers after aerosol therapy in patients with cystic fibrosis.
    Vassal S; Taamma R; Marty N; Sardet A; d'athis P; Brémont F; Dalphin ML; Plésiat P; Rault G; Thubert J; Dominique S; Lemeland JF; Derelle J; Blech MF; Roussey M; Perrin M; Sautegeau A
    Am J Infect Control; 2000 Oct; 28(5):347-51. PubMed ID: 11029133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation measures for prevention of infection with respiratory pathogens in cystic fibrosis: a systematic review?
    Høiby N; Johansen HK
    J Hosp Infect; 2007 Apr; 65(4):374-5; author reply 375-6. PubMed ID: 17275952
    [No Abstract]   [Full Text] [Related]  

  • 7. [Detection and management of early Pseudomonas aeruginosa infection in patients with cystic fibrosis].
    Kernen Y; Sauty A; Roulet M
    Rev Med Suisse; 2005 Mar; 1(9):637-8, 640. PubMed ID: 15813341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Anti-Pseudomonas aeruginosa (Pa) antibiotic therapy and cystic fibrosis].
    Bellon G; Gilly R
    Rev Mal Respir; 1991; 8(2):263. PubMed ID: 1907014
    [No Abstract]   [Full Text] [Related]  

  • 9. Prevalence of resistant Pseudomonas aeruginosa with elective and rescue intravenous antibiotic regimens in children with cystic fibrosis.
    Smyth E; David TJ; Patel L; Ashcroft P; Sanyal D; Vyas J
    Int J Antimicrob Agents; 2005 Jul; 26(1):95-6. PubMed ID: 15970432
    [No Abstract]   [Full Text] [Related]  

  • 10. Approaches to the treatment of initial Pseudomonas aeruginosa infection in children who have cystic fibrosis.
    Lahiri T
    Clin Chest Med; 2007 Jun; 28(2):307-18. PubMed ID: 17467550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neonatal screening for cystic fibrosis does not affect time to first infection with Pseudomonas aeruginosa.
    Baussano I; Tardivo I; Bellezza-Fontana R; Forneris MP; Lezo A; Anfossi L; Castello M; Aleksandar V; Bignamini E
    Pediatrics; 2006 Sep; 118(3):888-95. PubMed ID: 16950978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pseudomonas aeruginosa and cystic fibrosis: unusual bacterial adaptation and pathogenesis.
    Govan JR; Harris GS
    Microbiol Sci; 1986 Oct; 3(10):302-8. PubMed ID: 3155268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [How should initial colonization by Pseudomonas aeruginosa be treated in patients with cystic fibrosis?].
    David V
    Rev Mal Respir; 2003 Apr; 20(2 Pt 2):S113-7. PubMed ID: 12910143
    [No Abstract]   [Full Text] [Related]  

  • 14. Patient risk of contact with respiratory pathogens from inanimate surfaces in a cystic fibrosis outpatient clinic. A prospective study over a four-year period.
    Festini F; Taccetti G; Mannini C; Campana S; Mergni G; Vignoli N; Allegretti N; Ravenni N; Cocchi P; Neri S; Repetto T; de Martino M
    Pediatr Pulmonol; 2007 Sep; 42(9):779-84. PubMed ID: 17639586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome diversity of Pseudomonas aeruginosa isolates from cystic fibrosis patients and the hospital environment.
    Finnan S; Morrissey JP; O'Gara F; Boyd EF
    J Clin Microbiol; 2004 Dec; 42(12):5783-92. PubMed ID: 15583313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transmission of Pseudomonas aeruginosa in children with cystic fibrosis attending summer camps in The Netherlands.
    Brimicombe RW; Dijkshoorn L; van der Reijden TJ; Kardoes I; Pitt TL; van den Broek PJ; Heijerman HG
    J Cyst Fibros; 2008 Jan; 7(1):30-6. PubMed ID: 17532271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microbiological background for anti-Pseudomonas aeruginosa vaccination in cystic fibrosis.
    Bauernfeind A; Przyklenk B
    Behring Inst Mitt; 1997 Feb; (98):256-61. PubMed ID: 9382748
    [No Abstract]   [Full Text] [Related]  

  • 18. [Pseudomonas aeruginosa infection in cystic fibrosis. The importance of early antibiotic therapy].
    Dutau G; Brémont F
    Rev Mal Respir; 1990; 7(3):183-5. PubMed ID: 2114027
    [No Abstract]   [Full Text] [Related]  

  • 19. Diagnostic value of serum antibodies in early Pseudomonas aeruginosa infection in cystic fibrosis patients.
    Ratjen F; Walter H; Haug M; Meisner C; Grasemann H; Döring G
    Pediatr Pulmonol; 2007 Mar; 42(3):249-55. PubMed ID: 17243185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Communicability of Pseudomonas aeruginosa in a cystic fibrosis summer camp.
    Speert DP; Lawton D; Damm S
    J Pediatr; 1982 Aug; 101(2):227-8. PubMed ID: 6808106
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.